TempraMed Technologies (HAM:9DY) Issuance of Debt: €0.97 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:9DY TempraMed Technologies Ltd HAM:9DY
7 GF Score
Price €0.19
! 5 Warning Signs
View Full Analysis

What is TempraMed Technologies Issuance of Debt?

TempraMed Technologies HAM:9DY -3.12% 7 Issuance of Debt is €0.97 Mil as of Jun. 2026. GuruFocus rates HAM:9DY with a GF Score™ of 7/100. The stock has 5 warning signs investors should review.

TempraMed Technologies's Issuance of Debt for the three months ended in Jun. 2026 was €0.38 Mil.

TempraMed Technologies's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was €0.97 Mil.

TempraMed Technologies Issuance of Debt Related Terms

TempraMed Technologies Issuance of Debt Historical Data

* Premium members only.

The historical data trend for TempraMed Technologies's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TempraMed Technologies Issuance of Debt Chart

TempraMed Technologies Annual Data
Trend Dec23 Dec24 Dec25
Issuance of Debt
0.00 1.20 2.19

TempraMed Technologies Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 -1.41 2.01 0.00 0.38
HAM:9DY
7GF Score
TempraMed Technologies Ltd HAM:9DY
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TempraMed Technologies Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of €0.97 Mil mean?
TempraMed Technologies (HAM:9DY) has a Issuance of Debt of €0.97 Mil as of Jun. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on TempraMed Technologies and its competitors.
Is TempraMed Technologies' Issuance of Debt too high?
TempraMed Technologies' current Issuance of Debt is €0.97 Mil. Overall, TempraMed Technologies has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' Issuance of Debt compare to ABT and SYK?
TempraMed Technologies' Issuance of Debt of €0.97 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Medical Devices & Instruments company?
A good Issuance of Debt depends on the Medical Devices & Instruments industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on TempraMed Technologies and its competitors. TempraMed Technologies's current Issuance of Debt is €0.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (HAM:9DY) has a current Issuance of Debt of €0.97 Mil. The current Issuance of Debt is €0.97 Mil. TempraMed Technologies' overall GF Score™ is 7/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For TempraMed Technologies (HAM:9DY), the current Issuance of Debt is €0.97 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TempraMed Technologies Business Description

Other Exchanges VIVI:Canada
Address Heh B’Iyar 14, Tel-Aviv, ISR, 6209307
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
7GF Score

Get the complete analysis for HAM:9DY

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.19
Price